AVL-101

N/A

Report date: 2026/05/12 15:11:34

Base Information

Drug NameAVL-101
Drug Alias NameAVL-101AVL101
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsCervical Intraepithelial NeoplasiaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAnweituo (Gu'an) Biopharmaceutical Co LtdBeijing Anweituo Biopharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShandong Guoyuan Technology Development Co LtdAnweituo (Gu'an) Biopharmaceutical Co LtdBeijing Anweituo Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCervical Intraepithelial Neoplasia
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A